Document is current
Any future updates will be listed below
-
Authors
Nogueras-Gonzalez, Graciela M.
Inam, Mehmet Enes
Msadabwe, Susan
Lee, Kamaria L
Njala, Bernadette
Sakala, Dyness
Chitula, Mwando
Montealegre, Jane
Peterson, Susan K.
Chiao, Elizabeth
Lin, Lilie L.
-
Funding
Funding for this research was provided by:
National Cancer Institute (R01CA284623)
- License Information
-
More Information
Article History
Received: 5 January 2026
Accepted: 4 June 2026
First Online: 9 July 2026
Declarations
:
: All participants provided informed consent prior to enrollment in the study. The study protocol was reviewed and approved by the University of Zambia’s Biomedical Research Ethics Committee and by the Institutional Review Board at The University of Texas MD Anderson Cancer Center. All local and collaborating investigators have completed Human Subjects Training and international Council for Harmonization (ICH) E6(R3) good Clinical Practice Training.
: L.L.L. reports grants/contracts from Varian, AstraZeneca, and Pfizer; and honoraria for serving on scientific advisory boards (Merck and Trevarx).
